# US 2008/0187524 A1 · Cellular Therapy to Heal Vascular Tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0187524 A1
- Document ID: US20080187524A1
- Status: Published application
- Kind: A1
- Application number: 12/062,230
- Filed: 2008-04-03
- Published: 2008-08-07
- Earliest claimed: 2003-04-25
- Assignees: Medtronic Vascular, Inc.
- Inventors: Brian Fernandes; Jack Chu; Prema Ganesan
- Web page: https://patentgrep.com/patent/US20080187524A1

## CPC

- A61F 2/07: Stent-grafts
- A61P 7/00: Drugs for disorders of the blood or the extracellular fluid
- A61F 2002/065: {Y-shaped blood vessels}
- A61F 2002/077: {having means to fill the space between stent-graft and aneurysm wall, e.g. a sleeve}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention encompasses methods and apparatus for minimizing the risks inherent in endovascular grafting for blood vessel therapy and repair. The invention involves delivering adult stem cells, embryonic stem cells, progenitor cells, fibroblasts, or smooth muscle cells to the diseased blood vessel.

## Claims

### Claim at position 1

1-30. (canceled)

### Claim 31

A method of treating an aneurysm in an individual at the aneurysmal site using self-derived cells, comprising:
harvesting adult stem cell-containing tissue from the individual wherein said tissue is selected from the group consisting of adipose tissue, bone marrow and peripheral blood;
isolating adult stem cells from the tissue; and
delivering the isolated adult stem cells directly to the wall of a blood vessel at said aneurysmal site by liquid delivery means wherein said blood vessel wall is repaired and said aneurysm is treated in said individual.

### Claim 32 (depends on 31)

The method of claim 31, wherein the harvesting step is accomplished by liposuction, drawing blood, or harvesting bone marrow.

### Claim 33 (depends on 31)

The method of claim 31, wherein the adult stem cells are isolated by growth in selective medium, by density centrifugation, fluorescence activated cell sorting or by magnetic activated cell sorting.

### Claim 34 (depends on 31)

The method of claim 31, wherein the adult stem cells are isolated by assaying for adult stem cell-specific a actin, calponin, smooth muscle myosin heavy chain, β-tubulin or vimentin expression.

### Claim 35 (depends on 31)

The method of claim 31, further comprising the step of modifying the adult stem cells after the isolating step.

### Claim 36 (depends on 35)

The method of claim 35, wherein the modifying step is accomplished by genetic engineering.

### Claim 37 (depends on 36)

The method of claim 36, wherein the adult stem cells are genetically engineered to produce at least one cellular factor selected from the group of collagen.
